Expertise in
6
conditions

Javier M. Puente

Madrid, MD, ES 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
Madrid, MD, ES 

Overview

Javier Puente practices practicing medicine in Madrid, Spain.

Mr. Puente is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Nephrectomy.

He is actively involved in clinical research, co-authoring 97 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Madrid, MD, Spain
Other Locations
Oviedo, AS, Spain
Barcelona, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

International Registry for Men With Advanced Prostate Cancer (IRONMAN)
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Enrollment Status: Recruiting
Publish Date: May 22, 2026
Intervention Type: Other
Observational Retrospective-prospective Study in Patients With Genitourinary Tumors Presenting COVID-19 Infection (SOGUG-COVID-19)
Observational Retrospective-prospective Study in Patients With Genitourinary Tumors Presenting COVID-19 Infection (SOGUG-COVID-19)
Enrollment Status: Completed
Publish Date: April 01, 2025
A Phase I-II Study to Evaluate the Efficacy and Safety of Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer After Failure to First-line Platinum-based Chemotherapy
A Phase I-II Study to Evaluate the Efficacy and Safety of Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer After Failure to First-line Platinum-based Chemotherapy
Enrollment Status: Completed
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drugs: Niraparib, Cabozantinib
Study Phase: Phase 1/Phase 2
Phase II Multicentre, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Avelumab With Gemcitabine/Carboplatin Versus Gemcitabine/Carboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma (UC) Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.
Phase II Multicentre, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Avelumab With Gemcitabine/Carboplatin Versus Gemcitabine/Carboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma (UC) Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.
Enrollment Status: Completed
Publish Date: October 18, 2023
Intervention Type: Combination product
Study Drugs: Avelumab 10mg/kg with Carboplatin/Gemcitabine, Carboplatin/Gemcitabine Alone
Study Phase: Phase 2
A Multi-arm, Multi-stage, Randomized Phase II/III Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
A Multi-arm, Multi-stage, Randomized Phase II/III Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
Enrollment Status: Unknown
Publish Date: October 26, 2022
Intervention Type: Drug
Study Drugs: Ipilimumab, Nivolumab, Docetaxel, ADT
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

97 Total Publications

Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer.
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer.
Journal: The New England journal of medicine
Published: July 22, 2026

Frequently Asked Questions about Javier M. Puente

Is Javier M. Puente a top-rated expert for Urothelial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Javier M. Puente is classified as an Distinguished expert for Urothelial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Javier M. Puente participate in research or clinical trials?

Yes. Javier M. Puente has published 97 articles and abstracts on conditions like Urothelial Cancer. You can view a list of Javier M. Puente's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Puente's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile